INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is an adult-onset motor neuron disease leading to paralysis and death within 2 to 5 years after diagnosis (Jackson & Bryan, 1998) . ALS occurs mainly sporadically. However, between 5 and 10% of the cases are familial, although clinically indistinguishable from the sporadic form (Mitsumoto et al., 1998) . A subset of familial ALS cases (ϳ20%) is caused by missense mutations in the gene encoding the Cu,Zn superoxide dismutase (SOD1) (Rosen et al., 1993) . To date, over 60 different SOD1 mutations have been reported in familial ALS (Shaw et al., 1998) . Transgenic mouse studies provided evidence that the pathogenic properties of SOD1 mutations arise from a gain of a novel toxic function rather than a down-or upregulation of the SOD1 activity. Expression of various SOD1 mutants in transgenic mice did not result in a reduction of total SOD1 activity, but nevertheless induced a progressive motor neuron disease (Gurney et al., 1994; Ripps et al., 1995; Wong et al., 1995; Bruijn et al., 1997) . Moreover, mice bearing a targeted disruption of the SOD1 gene did not develop motor neuron disease (Reaume et al., 1996) . Finally, altering the levels of wild-type SOD1 did not affect the course of disease induced by concomitant expression of mutant SOD1 proteins in mice (Bruijn et al., 1998) .
Abnormal inclusion bodies containing neurofilaments are a pathological hallmark of ALS, including cases linked to SOD1 mutations (Carpenter, 1968; Hirano et al., 1996; Rouleau et al., 1996) . The discovery of mutations in the neurofilament heavy (NF-H) gene in some ALS cases (Figlewicz et al., 1994; Tomkins et al., 1998; Al-Chalabi et al., 1999) together with the finding that motor neuron dysfunction in mice can result from disorganized neurofilaments (Côté et al., 
